IBA (Ion Beam Applications), the world’s leading provider of proton therapy solutions for the treatment of cancer, announces that it has to issue a transparency notification, in accordance with Articl ...

Deutschland unterstützt die Ukraine mit Ausrüstungs- und Waffenlieferungen – aus Beständen der Bundeswehr und durch Lieferungen der Industrie, die aus Mitteln der Ertüchtigungshilfe der ...

Kelsterbach/Frankfurt am Main, 16.04.2024: Zweite Messkampagne zu ultrafeinen Partikeln (UFP) im Rahmen von SOURCE FFR (Study On Ultra-fine Particles in the Frankfurt Airport Region) auf dem Gelände ...

Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the United States (U.S.) Food and Drug Administration (FDA) has granted Fast Track designation[1] for the Company's in ...

On January 23, 2024, the Board increased Liberty’s existing share repurchase authorization announced July 25, 2022 to $750 million, a $250 million increase from the previously authorized and upsized ...

SAN MATEO, Calif., April 08, 2024--Model N (NYSE: MODN), a leader in revenue optimization and compliance for pharmaceutical, medtech, and high-tech innovators, today announced that it has entered into ...

Continuous Kesimpta® treatment for up to six years showed sustained efficacy in recently diagnosed (=3 years) treatment-naïve people living with ...